In both human and murine cancer cell lines, marker-based CRISPR screening showed that SEPHS1/Sephs1 knockout significantly increased MHC-I expression, suggesting enhanced tumor immunogenicity (Fig. 2B). This evidence concerns the gene SEPHS1 and neoplasm.